TNFSF14 and neoplasm: Given that we had previously demonstrated anti-tumor immune responses, increased TIL, and support of TIL proliferation in CRC with tumor necrosis factor superfamily LIGHT [16, 18, 51], we endeavored to combine LIGHT and BATs together.